NISHA PATEL: Open Payments
NPI 1083175236 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 44 payments from 15 companies in 2025. Trend: 2023 $448 · 2024 $435 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $199 |
| Ardelyx, Inc. | 5 | $105 |
| Phathom Pharmaceuticals, Inc. | 7 | $99 |
| Madrigal Pharmaceuticals | 4 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| ABBVIE INC. | 3 | $68 |
| Lilly USA, LLC | 2 | $51 |
| Aimmune Therapeutics, Inc. | 2 | $50 |
| 180 Medical, Inc. | 2 | $42 |
Products named: TREMFYA, IBSRELA, VOQUEZNA, REZDIFFRA, XIFAXAN, ENTYVIO, OMVOH, ZENPEP.
Industry payments across FL — which companies pay providers there.
